TYPE 1 DIABETES AND BONE HEALTH: ROLE OF REDUCED BONE DENSITY AND FRACTURE RISK
DOI:
https://doi.org/10.15547/tjs.2025.s.01.005Keywords:
type 1 diabetes mellitus, bone fractures, bone density, preventionAbstract
Type 1 diabetes mellitus (T1DM) is an autoimmune disease that affects not only glycemic control but also bone remodeling, leading to reduced bone mineral density (BMD) and increased fracture risk. The aim of this study was to investigate the relationship between T1DM and bone health, focusing on reduced BMD and fracture risk. Methods included a systematic review of the scientific literature from the last 10 years in the Pub Med, Scopus and Web of Science databases with the keywords: diabetes type 1, bone fractures, BMD, prevention and accessible full text of the scientific reports from which this review was prepared. The results of the systematic review indicate that the duration of the disease, impaired insulin and calcium metabolism, as well as chronic hyperglycemia contribute to impaired osteogenesis and increased risk of fractures. The most susceptible to fractures in type 1 diabetes are the bones of the femoral neck and lumbar spine. The accompanying complications, such as diabetic retinopathy, neuropathy and hypoglycemic episodes, increase the risk of falls and fractures. Conclusion: optimal blood glucose control, adequate calcium and vitamin D intake, physical activity and regular monitoring of BMD can minimize subsequent fracture risks and prevent bone health.
References
Atkinson, M.A., Eisenbarth, G.S., Michels A.W., Type 1 diabetes. Lancet. 398 (10313): 92–106. https://doi:10.1016/S0140-6736 (21) 01345-2. 2021.
Vora, J., Simpson, R., Bell, K., et al., Bone health in children and adolescents with type 1 diabetes: current concepts and future directions. Pediatr Diabetes. 21 (6): 951–960. https://doi:10.1111/pedi.13038. 2020.
Ferrari, S.L., Bianchi, M.L., Eisman, J.A., et al., Bone health and fracture risk in type 1 diabetes: new insights. Nat Rev Endocrinol. 18 (4): 211–223. https:// doi:10.1038/s41574-021-00590-4. 2022.
Shah, V.N., Shah, C.S., Snell-Bergeon, J.K., Type 1 diabetes and risk for osteoporosis. Curr Opin Endocrinol Diabetes Obes. 30 (1): 17–24. https://doi:10.1097/MED.0000000000000792. 2023.
Weber, D.R., Haynes, K., Leonard, M.B., et al., Lower bone density and altered bone geometry in adolescents with type 1 diabetes. J Clin Endocrinol Metab. 105 (12): e4489–e4499. https://doi:10.1210/clinem/dgaa579. 2020.
Norris, R., Parker, M., Diabetes mellitus and hip fracture: a study of 5966 cases. Injury. 42: 1313–6. 2011.
Humphers, J.M., Shibuya, N., Fluhman, B.L., Jupiter, D., The impact of glycosylated hemoglobin and diabetes mellitus on wound-healing complications and infection after foot and ankle surgery. J Am Podiatr Med Assoc. 104: 320–9. 2014.
Hu, F., Jiang, C., Shen J., Tang, P., Wang, Y., Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis. Injury. 43: 676–85. 2012.
Furst, J.R., Bandeira, F., Fan, W.W., et al., Advanced glycation end products and bone material strength in type 1 diabetes. J Clin Endocrinol Metab. 105 (3): e1318-e1326. https://doi:10.1210/clinem/dgz227. 2020.
Yamamoto, M., Yamagishi, S., Role of advanced glycation end products in osteoporosis. Curr Pharm Des. 27 (15): 1863-1869. https://doi:10.2174/1381612827666210210124517. 2021.
Napoli, N., Chandran, M., Pierroz, D.D, et al., Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 13 (4): 208–19. 2017.
Shu, A., Yin, M.T., Stein, E., et al., Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int. 23 (2): 635–41. 2012.
Saha, M.T., Salo, M.K., Kautiainen, H., et al., Bone mass and structure in adolescents with type 1 diabetes. J Pediatr Endocrinol Metab. 34 (1): 55-62.doi:10.1515/jpem-2020-0343. 2021.
Schwetz, V., Pieber, T.R., Obermayer-Pietsch, B., The impact of type 1 diabetes mellitus on bone metabolism. Front Endocrinol (Lausanne). 12: 660363. https://doi:10.3389/fendo.2021.660363. 2021.
Ferrari, S.L., Abrahamsen, B., Napoli, N., et al., Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int. 29 (12): 2585–96. 2018.
Hammed, A., Warren, R.E., Javed, A., Psychosocial impact of fractures and chronic disease in adolescents with type 1 diabetes. Diabetes Res Clin Pract. 162: 108114. https:// doi:10.1016/j.diabres. 2020.108114. 2020.
International Diabetes Federation. IDF Diabetes Atlas 11th Edition. 2024.
Elhadd, T., Al Amoudi, A., Alzahrani, A., Bone health in people with type 1 diabetes: an overlooked aspect. Front Endocrinol (Lausanne). 13: 845373. 2022.
Zhukouskaya, V.V., Eller-Vainicher, C., Veksler-Lublinsky, I., et al., Bone health in type 1 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 106 (12): e5014–e5027. 2021.
Vestergaard, P., Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int. 18 (4): 427–44. 2007.
Schneider, A.L., Williams, E.K., Brancati, F.L., Blecker, S., Coresh, J., Selvin, E., Diabetes and risk of fracture-related hospitalization: the Atherosclerosis Risk in Communities Study. Diabetes Care 36:1153–1158. 2013.
Li, C.I., Liu, C.S., Lin, W.Y., Meng, N.H., Chen, C.C., Yang, S.Y., et al., Glycated hemoglobin level and risk of hip fracture in older people with type 2 diabetes: a competing risk analysis of Taiwan Diabetes Cohort Study. J Bone Miner Res 30: 1338–1346. 2015.
Vestergaard, P., Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int. 18 (4): 427–44. 2007.
Mitchell, D., Caksa, S., Joseph, T., Bouxsein, M., Misra, M., Elevated HbA1c is associated with altered cortical and trabecular microarchitecture in girls with type 1 diabetes. J Clin Endocrinol Metab. 105: dgz221. 2020.
Zhang, Y., Wang, C., Yu, M., Zhao, X., Oxidative stress and inflammation mediate the effects of type 1 diabetes on bone health: A review. J Diabetes Res. 2021: 8851723. https://doi:10.1155/2021/8851723. 2021.
Kanis, J.A., Assessment of osteoporosis at the primary health care level. World Health Organization Scientific Group. University of Sheffield, WHO Collaborating Centre for Metabolic Bone Diseases. 2008.
Alhuzaim, O., Lewis, E., Lovblom, L., et al., Bone mineral density in patients with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Type 1 Diabetes. J Diabetes Complicat. 33: 107324. 2019.
Thrailkill, K.M., Liu, L., Wahl, E.C., et al., Bone formation is impaired in a model of type 1 diabetes. Diabetes. 54 (10): 2875–81. 2005.
Dahl, C., Nielsen, T.L., Rix, M., et al., Diabetic bone disease: current knowledge and future directions. Curr Osteoporos Rep. 11 (2): 123-132. 2013.
Nguyen, V.H., Tinsley, L., Yu, E.W., Diabetes, bone health, and fracture risk: Current concepts and clinical implications. Curr Osteoporos Rep. 21 (1): 1-10. https://doi:10.1007/s11914-022-00747-3. 2023.
Morales-Palomo, F., Ramirez-Jimenez, M., Ortega, J.F., et al., Effects of exercise on bone health in patients with type 1 diabetes. A randomized controlled trial. Bone. 168: 116602. https://doi:10.15547/tjs.2024.01.009. 2023.
Petrova, M., Ivanova, R., Velikova, T., Individualized assessement of skeletal health in type 1 diabetes patients: A clinical perspective. Trakia J Sci. 22 (1): 55-63. https://doi:10.15547/tjs.2024.01.009. 2024
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
